These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Delineating patient errors in an intracavernosal injection program. Furtado TP, Teloken PE, Ortega Y, Narus J, Wolchasty NP, Mulhall JP. J Sex Med; 2024 May 28; 21(6):529-532. PubMed ID: 38660738 [Abstract] [Full Text] [Related]
15. Medical treatment of impotence with papaverine and phentolamine intracavernosal injection. Dinsmore WW. Ulster Med J; 1990 Oct 28; 59(2):174-6. PubMed ID: 2278115 [Abstract] [Full Text] [Related]
17. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure. Purvis K, Brekke I, Christiansen E. Int J Impot Res; 1996 Mar 28; 8(1):9-16. PubMed ID: 8735188 [Abstract] [Full Text] [Related]
18. [The intracavernosal administration of papaverine in the diagnosis and treatment of sexual disorders in men]. Gorpinchenko II, Khudaĭberdiev NA. Vrach Delo; 1989 Oct 28; (10):102-5. PubMed ID: 2617964 [Abstract] [Full Text] [Related]
19. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis. Elhanbly S, Schoor R, Elmogy M, Ross L, Hegazy A, Niederberger C. J Urol; 2002 Jan 28; 167(1):192-6. PubMed ID: 11743303 [Abstract] [Full Text] [Related]
20. Anatomic and Functional Outcome Following Distal Shunt and Tunneling for Treatment İschemic Priapism: A Single-Center Experience. Ortaç M, Çevik G, Akdere H, Ermeç B, Kadıoğlu A. J Sex Med; 2019 Aug 28; 16(8):1290-1296. PubMed ID: 31230939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]